Release Date: 06/04/22 11:40 Summary: Units on Issue Disclosure - Mar 2022 Price Sensitive: No Download Document 116.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%